Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
HC Bioscience, Inc. logo — A New Era of Protein Engineering with tRNA Therapeutics.

HC Bioscience, Inc.

A New Era of Protein Engineering with tRNA Therapeutics.

Founded 2021 United States Cambridge, United States 4 employees Total: $40.00M Biotechnology, Health Care +1

General Information

Company Name HC Bioscience, Inc.
Founded Year 2021
Location United States Cambridge, United States
Employees 4
Industries Biotechnology, Health Care, Life Sciences
Social

BounceWatch is an independent company data service, not affiliated with HC Bioscience, Inc.. To contact HC Bioscience, Inc., visit hcbioscience.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does HC Bioscience, Inc. compare?

A PDF of HC Bioscience, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting HC Bioscience, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About HC Bioscience, Inc.

HC Bioscience, Inc., founded in 2021, is pioneering advancements in the biotechnology landscape with its focus on tRNA-based therapeutics. Known for its slogan, "A New Era of Protein Engineering with tRNA Therapeutics," the company is tackling protein dysfunction by leveraging first-in-class therapies.

Positioned at the intersection of Biotechnology, Health Care, and Life Sciences, HC Bioscience is dedicated to developing solutions for genetically defined diseases. Notably, their approach offers the versatility to address numerous diseases with a single therapy, independent of gene type or mutation location.

Operating out of the United States, the company has already attracted interest from notable investors. Most recently, CureDuchenne Ventures provided an early VC investment on 01 February 2023. This reflects growing confidence in their innovative therapies for targeted protein editing.

Business keywords: Protein Engineering, tRNA Therapeutics, Protein Dysfunction, Precision Medicine, Genetically Defined Diseases, Protein Editing, Proteome Modification, First-in-Class Therapies, Biotechnology Innovation, Genomic Medicine, Context Agnostic tRNA, Therapeutic Protein Editing, Single tRNA Therapy

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC Undisclosed 1
CureDuchenne Ventures
CureDuchenne Ventures
01 Feb 2023
Series A $16.00M 5
8VC Arch Venture Partners Panacea Venture
8VC, Arch Venture Partners +3
01 Nov 2022
Series A $24.00M 4
8VC Arch Venture Partners Takeda Ventures
8VC, Arch Venture Partners +2
01 Feb 2022

HC Bioscience, Inc. Alternatives & Competitors

View All Alternatives
HC Bioscience, Inc. vs
Gemini Therapeutics
Gemini Therapeutics

Pioneering precision treatments for genetic eye diseases with a robust pipeline of innovative therap...

Post-IPO Equity
Biopharma, Biotechnology
HC Bioscience, Inc. vs
Alumis
Alumis United States

Transforming the lives of patients living with immune-mediated diseases using a precision approach.

Series C
249 employees
Biotechnology, Health Care
HC Bioscience, Inc. vs
HuidaGene Therapeutics
HuidaGene Therapeutics China

辉大，给患者回答 | Answering the Patients！

Series C
27 employees
Biopharma, Biotechnology
Also compare with: HC Bioscience, Inc. vs Alltrna Alltrna View all alternatives

FAQ About HC Bioscience, Inc.

A New Era of Protein Engineering with tRNA Therapeutics.
HC Bioscience, Inc. was founded in 2021.
HC Bioscience, Inc. is headquartered in Cambridge, United States.
HC Bioscience, Inc. operates in Biotechnology, Health Care and Life Sciences. Its work centres on Protein Engineering, tRNA Therapeutics, Protein Dysfunction and Precision Medicine.
HC Bioscience, Inc. has approximately 4 employees.
HC Bioscience, Inc. has completed 3 funding rounds, raising a total of $40.00M.
Top alternatives and competitors to HC Bioscience, Inc. include Gemini Therapeutics, Alumis, HuidaGene Therapeutics, miRecule, Inc., Alltrna. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HC Bioscience, Inc. and Gemini Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for HC Bioscience, Inc., https://bouncewatch.com/company/hc-bioscience-inc, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout